Answers are grounded in this paper and cite their sources.
Medhya rasayana is a classical Ayurvedic formulation comprising neuroactive herbs such as Bacopa monnieri (L.) Wettst and Centella asiatica (L.) Urb., whose nomenclature corresponds to the latest revision in World Flora Online (accessed on 31 July 2025). It is traditionally used to enhance memory, cognition, and overall brain health, as well as to manage mental illness and neurological disorders across different age groups. However, the underlying molecular mechanism remains largely undefined. In this study, we aimed to investigate whether a rasayana preparation of B. monnieri (Bm) and C. asiatica (Ca) delays the onset or progression of Alzheimer’s disease (AD) in an amyloid beta oligomer (AβO)-injected mouse model by preventing key hallmarks, including cognitive impairment and neuroinflammation. Bm and Ca rasayana formulations were orally administered to healthy 16-week-old mice for two months, followed by the induction of AD via stereotaxic injection of AβO into the hippocampus. Seven days post-AβO injection, a battery of behavioural tests was conducted to evaluate the impact of rasayanas on cognitive outcomes. Furthermore, transcriptomic (RNA-seq) and metabolomic (LC‒MS) profiling of hippocampal tissue was performed to investigate the molecular and biochemical effects of rasayana intervention. The results of the behavioral data revealed that AβO injection impaired spatial and social memory, whereas rasayana pretreatment preserved cognitive function and prevented AβO-induced deficits in the AD mouse model. Furthermore, transcriptomic analysis of the hippocampus with or without rasayana pretreatment revealed that the rasayana formulation beneficially modulated key biological processes, including the inflammatory response, cytokine and TNF regulation, positive regulation of the MAPK cascade, and antigen processing and presentation. Metabolomic analysis further revealed that rasayana pretreatment conferred neuroprotection via glutathione and pyrimidine metabolism. Our findings indicate that pretreatment with Bm and Ca. rasayana prevents AβO-induced neuroinflammation and cognitive deficits in an AD mouse model by suppressing proinflammatory pathways and restoring redox balance, suggesting its potential for delaying the onset of disease progression. • Medhya rasayana , an ayurvedic formulation specifically used to enhance overall cognitive health by nourishing and rejuvenating the brain and nervous system. • Bacopa monnieri (L.) Wettst. (Bm) and Centella asiatica (L.) Urb. (Ca) are the key Medhya rasayana herbs that possess neuroprotective properties. • Pretreatment of Bm and Ca rasayana prevented AβO-induced cognitive impairment in AD mouse model. • Bm and Ca pretreatment prevented the AD-associated upregulation of neuroinflammatory pathways including cytokine regulation, MAPK cascade, and antigen presentation pathways. • Metabolomic analysis showed pretreatment of rasayana regulated glutathione and pyrimidine metabolism pathways. • This study found the potential of Bm and Ca rasayana to prevent or delay the onset of AD progression.
No takes yet. Share an insight, caveat, or question.
Maruthiyodan et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: